Aimei Health Technology Co., Ltd (AFJK)

Aimei Health Technology Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023
Selling, General & Admin	1.06	1.06	0.04
Operating Expenses	1.06	1.06	0.04
Operating Income	-1.06	-1.06	-0.04
Interest & Investment Income	2.85	3.62	0.3
Pretax Income	1.8	2.55	0.26
Net Income	1.8	2.55	0.26
Net Income to Common	1.8	2.55	0.26
Net Income Growth	599.09%	892.75%	-
Shares Outstanding (Basic)	8	9	2
Shares Outstanding (Diluted)	8	9	2
Shares Change (YoY)	251.99%	304.07%	-
EPS (Basic)	0.23	0.28	-
EPS (Diluted)	0.23	0.28	-
EBIT	-1.06	-1.06	-0.04

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q